Improved Survival With Enzalutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.22.00193
Abstract: Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co-primary or secondary analyses are not yet… read more here.
Keywords: end; placebo plus; plus adt; enzalutamide plus ... See more keywords